- Home
- A-Z Publications
- Current Medicinal Chemistry
- Previous Issues
- Volume 12, Issue 14, 2005
Current Medicinal Chemistry - Volume 12, Issue 14, 2005
Volume 12, Issue 14, 2005
-
-
p27kip1 Functional Regulation in Human Cancer: A Potential Target for Therapeutic Designs
Authors: B. Belletti, M. S. Nicoloso, M. Schiappacassi, E. Chimienti, S. Berton, F. Lovat, A. Colombatti and G. BaldassarreThe mitotic cell cycle is a tightly regulated process that ensures the correct division of one cell into two daughter cells. Progress along the different phases of the cell cycle is positively regulated by the sequential activation of a family of serine-threonine kinases called CDKs (Cyclin Dependent Kinases). Their activity is counteracted by small proteins known as CDK inhibitors (CKI) that ensure the correct timing of CDK activation i Read More
-
-
-
Bacterial Peptide Deformylase Inhibitors: A New Class of Antibacterial Agents
Authors: R. Jain, D. Chen, R. J. White, D. V. Patel and Z. YuanPeptide deformylase (PDF) is a prokaryotic metalloenzyme that is essential for bacterial growth but is not required by mammalian cells. Thus, it represents a selective and promising target for the development of new antibacterial agents. Since deformylase inhibitors have yet to be used clinically as antibacterial drugs, compounds targeting this enzyme should avoid cross-resistance with currently used antibacterial agents Read More
-
-
-
Inhibition of P450 17 as a New Strategy for the Treatment of Prostate Cancer
By F. LerouxThe cytochrome P450 monooxygenase enzyme system is involved in the synthesis and/or degradation of a large number of endogenous compounds and in the biotransformation of drugs and other xenobiotics. 17α-Hydroxylase-C17,20-lyase (P450 17, CYP 17) is the key enzyme of the androgen biosynthesis. As androgens have been implicated in the development and progression of prostate cancer, this enzyme has be Read More
-
-
-
Blast from the Past: The Aluminum's Ghost on the Lanthanum Salts
Authors: Caterina Canavese, Cristina Mereu, Maurizio Nordio, Enrico Sabbioni and Silvio AimeHyperphosphatemia is a common serious complication of chronic renal diseases, which needs appropriate continuous treatment in order to avoid ominous side effects. Therefore, oral chelating agents able to avoid phosphate absorption by the gut are mandatory. In the past, Aluminium salts, and more recently Calcium and Magnesium salts, and a synthetic resin polyallylamine hydrochloride have been employed, but Aluminiu Read More
-
-
-
Nucleotide Deoxysugars: Essential Tools for the Glycosylation Engineering of Novel Bioactive Compounds
Authors: Carsten Rupprath, Thomas Schumacher and Lothar EllingThe irreversible spread of new resistance mechanisms against existing therapeutical antibiotics has led to the development of technologies and strategies for the glycosylation engineering of novel antibiotics. Amino-, C-branched and O-methylated 6-deoxyhexoses play a favourite role in the biosynthesis of clinically important antibiotics like tylosin, erythromycin or oleandomycin and are essential for the antibiotic activity. They Read More
-
-
-
Drug Development and PET-Diagnostics for Alzheimer's Disease
Authors: Boris Schmidt, Hannes A. Braun and Rajeshwar NarlawarThe exact cause of Alzheimer's disease is still unknown; despite the dramatic progress in understanding. Most gene mutations associated with Alzheimer's disease point to the amyloid precursor protein and amyloid β. The α-, β- and γ-secretases are the three executioners of amyloid precursor protein processing. Significant progress has been made in the selective inhibition of these proteases, regardless of the availab Read More
-
-
-
Plasticity of the Streptomyces Genome-Evolution and Engineering of New Antibiotics
Authors: Daslav Hranueli, John Cullum, Bojan Basrak, Pavle Goldstein and Paul F. LongStreptomyces is a genus of soil dwelling bacteria with the ability to produce natural products that have found widespread use in medicine. Annotation of Streptomyces genome sequences has revealed far more biosynthetic gene clusters than previously imagined, offering exciting possibilities for future combinatorial biosynthesis. Experiments to manipulate modular biosynthetic clusters to create novel chemistries o Read More
-
Volumes & issues
-
Volume 32 (2025)
-
Volume 31 (2024)
-
Volume 30 (2023)
-
Volume 29 (2022)
-
Volume 28 (2021)
-
Volume 27 (2020)
-
Volume 26 (2019)
-
Volume 25 (2018)
-
Volume 24 (2017)
-
Volume 23 (2016)
-
Volume 22 (2015)
-
Volume 21 (2014)
-
Volume 20 (2013)
-
Volume 19 (2012)
-
Volume 18 (2011)
-
Volume 17 (2010)
-
Volume 16 (2009)
-
Volume 15 (2008)
-
Volume 14 (2007)
-
Volume 13 (2006)
-
Volume 12 (2005)
-
Volume 11 (2004)
-
Volume 10 (2003)
-
Volume 9 (2002)
-
Volume 8 (2001)
-
Volume 7 (2000)
Most Read This Month
Article
content/journals/cmc
Journal
10
5
false
en
